Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
62.6M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
3.68M
-
Shares change
-
+219K
-
Total reported value, excl. options
-
$16M
-
Value change
-
+$1M
-
Put/Call ratio
-
0.03
-
Number of buys
-
31
-
Number of sells
-
-19
-
Price
-
$4.34
Significant Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q2 2023
64 filings reported holding IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2023.
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.68M shares
of 62.6M outstanding shares and own 5.88% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (886K shares), RICE HALL JAMES & ASSOCIATES, LLC (849K shares), MAI Capital Management (485K shares), Richmond Brothers, Inc. (342K shares), GEODE CAPITAL MANAGEMENT, LLC (194K shares), Knoll Capital Management, LLC (100K shares), RENAISSANCE TECHNOLOGIES LLC (99.6K shares), BlackRock Inc. (55.4K shares), STATE STREET CORP (52.9K shares), and Stratos Wealth Partners, LTD. (49.2K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.